ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

LFWD vs CLGN // ALTMAN Z-SCORE & DEBT/EQUITY

Lifeward Ltd. (NASDAQ) VS. CollPlant Biotechnologies Ltd (NASDAQ) • 15-METRIC TALLY: LFWD 2 — CLGN 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LFWD VS. CLGN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC LFWD CLGN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 96.00% 64.80% +31.20 LFWD /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -17.60% 180.00% -197.60 CLGN /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 5/9 -1.00 CLGN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 44.8 56.3 -11.49 CLGN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $16.7M $12.7M $4.1M LFWD /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR LFWD REV CLGN REV LFWD GROSS % CLGN GROSS % LFWD FCF CLGN FCF
FY 2025 $1.4M $2.4M 98.0% 64.8% -$16.8M -$9.4M
FY 2024 $1.7M $515.0K 98.0% -50.0% -$21.7M -$14.6M
FY 2023 $435.0K $11.0M — — -$20.7M -$2.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LFWD // BETA —
CLGN // BETA —